Chief Executive Officer · Evolent Health, Inc. (EVH)

Seth Blackley

A named executive officer of Evolent Health in every fiscal year CompBrief holds from FY2017 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$14,240,154

FY2024: $11,136,185

1st of 5 named executive officers at Evolent Health by FY2025 total.

5 named officers on file for Evolent Health, FY2025

See an example →

What this number hides

The filing gives the total. Evolent Health’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed April 24, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-06.

Free

Get Seth Blackley’s full pay file as a PDF — free

More than this page: up to 10 years of Seth’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Seth Blackley and every company like it: Velarion Intel, free for 3 days, no card →

Seth Blackley compensation by year

Evolent Health Summary Compensation Table · all 9 fiscal years held
In US dollars, as Evolent Health reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$400,000$400,000$400,000$437,500$600,000$683,333$783,333$800,000$867,068
Bonus$200,000$0$250,000$700,000$1,125,000$1,094,000$1,200,000$0$660,000
Stock awards$750,000$1,200,000$2,400,000$2,823,800$4,789,685$5,935,881$6,934,655$10,322,385$12,699,086
Option awards$750,000$600,000$0$0$0$0$0$0$0
Non-equity incentive$0$0$0$0$0$0$0—$0
Pension and deferred compensation$0$0$0$0$0$0$0—$0
All other$10,800$11,000$2,667$11,400$11,600$12,200$13,200$13,800$14,000
Total$2,110,800$2,211,000$3,052,667$3,972,700$6,526,285$7,725,414$8,931,188$11,136,185$14,240,154

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Evolent Health, Inc. DEF 14A filed April 24, 2026, accession 0001193125-26-177267, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Evolent Health, Inc. filed document, accession 0001193125-26-177267. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

$2.1M
$2.2M
$3.1M
$4.0M
$6.5M
$7.7M
$8.9M
$11.1M
$14.2M
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU705,076$2,820,304—
RSU235,025$940,100—
RSU189,854$759,417—
RSU67,150$268,600—
RSU19,471$77,884—
RSU19,203$76,812—

Per the Outstanding Equity Awards at Fiscal Year-End table in Evolent Health, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

2 Form 4 lines since the FY2025 proxy (filed April 24, 2026)
current to 2026-11-06 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-07-01Grant or award—446,102$0.001,283,064
2026-07-01Tax withholding—10,297$5.741,272,767

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments Evolent Health discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Change in control and involuntary termination$4,020,000$4,540,217$46,293$8,606,510
Resignation for good reason, no change in control$1,980,000$4,215,659$34,719$6,230,378
Involuntary termination without cause$1,980,000$4,215,659$34,719$6,230,378
Change in control and resignation for good reason$4,020,000$4,540,217$46,293$8,606,510

Per the Potential Payments Upon Termination or Change in Control table in Evolent Health, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

Evolent Health’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Seth Blackley · this pageChief Executive Officer$14,240,154
Daniel McCarthyPresident$9,623,279
John JohnsonFormer Chief Financial Officer; Chief Strategy Officer$5,370,671
Jonathan WeinbergGeneral Counsel$2,639,664
Emily RaffertyFormer Chief Operating Officer; EVP, Customer Success$2,404,625

Board service

Evolent Health board · FY2021–FY2025

How this board is paid

Company policy: Evolent Health pays directors a $80,000 cash retainer and $180,000 in RSUs. As stated in Evolent Health's FY2025 proxy.

The full Evolent Health compensation record

free company brief

This page is one person within Evolent Health's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Evolent Health proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Evolent Health's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Evolent Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order EVH

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Seth Blackley's compensation dossier